12-1593463-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152441.3(FBXL14):āc.604C>Gā(p.Leu202Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,986 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152441.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBXL14 | NM_152441.3 | c.604C>G | p.Leu202Val | missense_variant | 1/2 | ENST00000339235.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBXL14 | ENST00000339235.4 | c.604C>G | p.Leu202Val | missense_variant | 1/2 | 1 | NM_152441.3 | P1 | |
WNT5B | ENST00000537031.5 | c.-58+18622G>C | intron_variant | 2 | P1 | ||||
WNT5B | ENST00000539198.5 | c.-57-37835G>C | intron_variant | 4 | |||||
WNT5B | ENST00000545811.5 | c.-57-37835G>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000520 AC: 13AN: 250138Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135526
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461630Hom.: 1 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727126
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 29, 2024 | The c.604C>G (p.L202V) alteration is located in exon 1 (coding exon 1) of the FBXL14 gene. This alteration results from a C to G substitution at nucleotide position 604, causing the leucine (L) at amino acid position 202 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at